| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |